Skip to main content
SpringerLink
Log in

The CanGèneTest Pan-Canadian Research Consortium on Genetic Laboratory Services

  • Chapter
  • First Online:
Quality Issues in Clinical Genetic Services

  • 714 Accesses

Key Points

Most important issues of Chapter:

• There is a need to enhance translation of genetic innovations into better care;

• Building of the evidence-base for their clinical validity and utility is necessary;

• One approach to streamline this process is multidisciplinary research;

• Involvement of decision makers at all levels is necessary to accelerate uptake;

• A systematic knowledge translation strategy is also important.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • AETMIS. Le syndrome du X fragile: la place du diagnostic moléculaire et du dépistage dans une approche intégrée des services. Blancquaert, I., Caron, L., and AETMIS. 2001.

    Google Scholar 

  • AETMIS. Le dépistage prénatal du syndrome de Down et d’autres aneuploïdies au premier trimestre de la grossesse. Framarin, A., and AETMIS. 2003.

    Google Scholar 

  • AETMIS. Contribution des analyses moléculaires des gènes BRCA1/2 à l’évaluation du risque de prédisposition au cancer du sein ou de l’ovaire: rapport sommaire. Tranchemontagne, J., Boothroyd, L., and Blancquaert, I., and AETMIS. 2006.

    Google Scholar 

  • AETMIS. La spectrométrie de masse en tandem et le dépistage néonatal sanguin au Québec. Makni, H., St-Hilaire, C., Robb, L., Larouche, K., and Blancquaert, I. [2007-03] – ID: 9944/9947. 2007.

    Google Scholar 

  • Andermann A, Blancquaert I, Beauchamp S, et al. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 2008 April; 86(4): 317–319.

    Article  PubMed  PubMed Central  Google Scholar 

  • CETS. Dépistage familial et diagnostic moléculaire de la dystrophie myotonique de Steinert. Conseil d’évaluation des technologies en santé, Gouvernement du Québec. 1997a.

    Google Scholar 

  • CETS. Dépistage familial et diagnostic moléculaire des dystrophies musculaires de Duchenne et de Becker. Conseil d’évaluation des technologies en santé, Gouvernement du Québec. 1997b.

    Google Scholar 

  • CETS. Tyrosinémie héréditaire de type I: contribution de la génétique moléculaire au dépistage familial des porteurs. Conseil d’évaluation des technologies en santé, Gouvernement du Québec. 1998.

    Google Scholar 

  • CETS. Les enjeux du dépistage et du diagnostic prénatal du syndrome de Down. Framarin, A., and AETMIS. Conseil d’évaluation des technologies en santé, Gouvernement du Québec 1999.

    Google Scholar 

  • Department of Health and Human Services of USA. U.S. System of Oversight of Genetic Testing: A response to the charge of the secretary of health and human services. SACGHS Secretary’s Advisory Committee on Genetics, H., and Society. April 2008.

    Google Scholar 

  • Gagne G, Reinharz D, Laflamme N, et al. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms. Clin Genet 2007; 71: 46–58.

    Article  CAS  PubMed  Google Scholar 

  • Gekas G, Gagné G, Bujold E, et al. Comparison of different strategies in prenatal screening for Down’s syndrome: cost effectiveness analysis of computer simulation. Br Med J 2009; 338: b138, (e-print). Will be updated with paper publication data.

    Article  Google Scholar 

  • Giroux S, Dube-Linteau A, Cardinal G, et al. Assessment of the prevalence of the 985A>G MCAD mutation in the French-Canadian population using allele-specific PCR. Clin Genet 2007; 71: 569–575.

    Article  CAS  PubMed  Google Scholar 

  • Giroux S, Elfassihi L, Cardinal G, et al. LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French-Canadian women. Bone 2007b; 40: 1299–1307.

    Article  CAS  PubMed  Google Scholar 

  • Giroux S, Elfassihi L, Rousseau F. CYP1A1: ethnic and population differences in allelic frequencies and interpretation of bone biology studies. J Bone Miner Res 2006; 21, 1959; author reply, 1960–1961.

    Article  Google Scholar 

  • Gravel K, Legare F, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals’ perceptions. Implement Sci 2006; 1: 16.

    Article  PubMed  PubMed Central  Google Scholar 

  • INSPQ. (in revision). Rapport d’évaluation de la pertinence du dépistage néonatal de l’anémie falciforme au Québec. Laflamme, N., Lindsay, C., Gagné, G., and Fortier, M. Institut National de Santé Publique du Québec, Gouvernement du Québec 2009.

    Google Scholar 

  • Ioannidis JP. Evolution and translation of research findings: from bench to where? PLoS Clin Trials 2006; 1: e36.

    Article  PubMed  PubMed Central  Google Scholar 

  • Khoury MJ, Gwinn M, Yoon PW, et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007; 9: 665–674.

    Article  PubMed  Google Scholar 

  • Lamothe L, Reinharz D, Paquette M. La construction émergente d’un champ organisationnel: le domaine de la génétique au Québec. In CALASS Marseille. 2007.

    Google Scholar 

  • Legare F, Moher D, Elwyn G, Leblanc A, and Gravel K. Instruments to assess the perception of physicians in the decision-making process of specific clinical encounters: a systematic review. BMC Med Inform Decis Mak 2007b; 7: 30.

    Article  PubMed  PubMed Central  Google Scholar 

  • Legare F, Stacey D, Forest PG. Shared decision-making in Canada: update, challenges and where next!. Z Arztl Fortbild Qualitatssich 2007c; 101: 213–221.

    PubMed  Google Scholar 

  • Légaré F, Ratté S, Stacey D, et al. Interventions for improving the adoption of shared decision making by healthcare professionals. (Protocol). Cochrane Database Syst Rev 2007; Art. No.: CD006732. DOI: 10.1002/14651858.CD006732.

    Google Scholar 

  • Miller F, Wilson B, Grimshaw J, et al. The Helix in the labyrinth: do we need genetic health services and policy research? Healthc Policy, Healthcare Policy/Politiques de Santé, 2008; 4(1): 30–38.

    PubMed  PubMed Central  Google Scholar 

  • O’Connor AM. Using decision aids to help patients navigate the “grey zone” of medical decision-making. CMAJ 2007; 176: 1597–1598.

    Article  PubMed  PubMed Central  Google Scholar 

  • OECD. Health Technologies and Decision Making. OECD, 2005.

    Google Scholar 

  • Petit E, Tassé AM, Godard B. An empirical analysis of the legal frameworks governing genetic services labs in Canadian provinces. Health Law Rev 2008; 16: 65–72.

    Google Scholar 

  • St-Jacques S, Grenier S, Charland M, et al. Decisional needs assessment regarding Down’s syndrome prenatal testing: A systematic review of women, their partners and health professionals’ perceptions. Prenatal Diagnosis 2008; 28(13): 1183–1203.

    Article  PubMed  Google Scholar 

  • Tassé AM and Godard B. L’encadrement législatif de la vente directe des tests génétiques et le système de santé québécois. Health Law J 2007; 15: 441–468.

    PubMed  Google Scholar 

  • Zimmern RL and Kroase M. The evaluation of genetic tests. J Public Health (Oxf) 2007 Sep; 29(3): 246–250, Epub 2007 May 24.

    Article  Google Scholar 

Download references

Acknowledgements

Dr François Rousseau holds a Fonds de Recherche en Santé du Québec national scientist award. The CanGèneTest research consortium on genetic laboratory services is funded by the Institute of Genetics of the Canadian Institutes for Health Research, the Heart and Stroke Foundation of Canada, the Canadian Agency for Drugs and Technologies in Health and the Canadian Genetics Diseases Network of Centres of Excellence.

Author information

Authors and Affiliations

  1. CanGèneTest Research Consortium on Genetic Laboratory Services, Département de biologie médicale, Faculté de medicine, Université Laval and Centre Hospitalier Universitaire de Québec, Québec, QC, Canada

    François Rousseau

Authors
  1. François Rousseau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to François Rousseau .

Editor information

Editors and Affiliations

  1. Dept. Clinical Genetics, University of Lund, Lund, 221 85, Sweden

    Ulf Kristoffersson

  2. Zentrum Kinderheilkunde, Inst. Humangenetik, Medizinische Hochschule Hannover (MHH), Carl-Neuberg-Str. 1, Hannover, 30625, Germany

    Jörg Schmidtke

  3. Center f. Human Genetics, Lab. For. Gen. & Mol. Arch., University of Leuven, Kapucijenvoer 33, Leuven, 3000, Belgium

    J. J. Cassiman

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Rousseau, F. (2010). The CanGèneTest Pan-Canadian Research Consortium on Genetic Laboratory Services. In: Kristoffersson, U., Schmidtke, J., Cassiman, J. (eds) Quality Issues in Clinical Genetic Services. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3919-4_2

Download citation

Publish with us

Policies and ethics

Search

Navigation